抗CCP抗体阳性伴肌肉骨骼症状个体超声亚临床滑膜炎缓解的相关因素:英国前瞻性队列研究
英国单中心前瞻性队列研究纳入抗CCP抗体阳性、有新发非特异性肌肉骨骼症状但无临床滑膜炎的个体,基线超声存在亚临床滑膜炎者中48%在12个月内缓解;低抗CCP滴度、类风湿因子阴性、仅一个关节受累及血沉≤15 mm/h为缓解的预测因素。
要点
- 抗CCP抗体阳性伴肌肉骨骼症状者中27%基线存在亚临床滑膜炎,12个月时48%缓解。
- 低抗CCP滴度、类风湿因子阴性、仅一个关节受累及血沉≤15 mm/h与12个月内缓解相关。
- 四项因素均具备者7/7缓解,均不具备者仅1/14缓解。
核心结论
- 在抗CCP抗体阳性个体中,亚临床滑膜炎约半数在12个月内消失,且与良好预后因素的存在相关。
- 亚临床滑膜炎应结合这些额外因素进行解读。
研究设计与样本
- 英国单中心前瞻性队列研究,纳入18岁及以上、抗CCP抗体阳性、有新发非特异性肌肉骨骼症状但无临床滑膜炎的个体。
- 基线行临床评估、血液检查、患者问卷及肌肉骨骼超声(腕、掌指、近端指间、跖趾关节),第一年每3个月随访,每12个月复查超声。
- 分析对象为基线至少一个关节存在亚临床滑膜炎(灰阶≥1且能量多普勒≥1)者,共122例,其中90例有12个月数据。
- 研究注册号ClinicalTrials.gov NCT02012764。
主要发现
- 2008年6月30日至2020年2月24日,451人同意参与CCP研究,122人(27%)基线存在亚临床滑膜炎,其中90人(74%)有12个月数据。
- 90例中平均年龄54.1岁(SD 12.5),女性63例(70%),男性27例(30%)。
- 90例中亚临床滑膜炎缓解43例(48%),持续47例(52%),持续者中27例(57%)在12个月内发展为临床滑膜炎。
- 多变量分析中,低抗CCP滴度(RR 1.52,95%CI 1.04-2.22)、类风湿因子阴性(RR 1.54,95%CI 0.92-2.58)、仅一个关节存在亚临床滑膜炎(RR 1.62,95%CI 1.04-2.50)及血沉≤15 mm/h(RR 1.82,95%CI 1.15-2.87)为12个月内亚临床滑膜炎缓解的预测因素。
- ROC曲线曲线下面积为0.84(95%CI 0.76-0.92;p<0.0001);四项因素均具备者7/7(100%)缓解,均不具备者仅1/14(7%)缓解。
关键数值与推荐
- 亚临床滑膜炎定义为灰阶≥1且能量多普勒≥1。
- 低抗CCP滴度:RR 1.52(95%CI 1.04-2.22)。
- 类风湿因子阴性:RR 1.54(95%CI 0.92-2.58)。
- 仅一个关节存在亚临床滑膜炎:RR 1.62(95%CI 1.04-2.50)。
- 血沉≤15 mm/h:RR 1.82(95%CI 1.15-2.87)。
临床怎么用
- 作者认为,亚临床滑膜炎应结合低抗CCP滴度、类风湿因子阴性、仅一个关节受累及血沉≤15 mm/h等额外因素进行解读。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subclinical synovitis occurs in a third of individuals at risk of rheumatoid arthritis. The objective of this study was to assess the reversibility of subclinical synovitis in individuals at risk of rheumatoid arthritis who are positive for anti-cyclic citrullinated peptide (CCP) antibody with musculoskeletal symptoms and investigate factors associated with its resolution within 12 months. METHODS: We conducted a single-centre, prospective, cohort study in the UK, recruiting individuals aged 18 years or older who were anti-CCP-positive with a new non-specific musculoskeletal symptom but no clinical synovitis. Referrals were made through primary or secondary care. Participants attended a baseline visit, which included a clinical assessment, blood tests, patient questionnaires, and a musculoskeletal ultrasound scan (ie, of wrists and metacarpophalangeal, proximal interphalangeal, and metatarsophalangeal joints), and then follow-up visits every 3 months for the first year, with a repeat ultrasound scan every 12 months. Participants with subclinical synovitis (ie, grey scale ≥1 and power Doppler ≥1) in at least one joint at baseline were selected for this analysis. Investigation of good prognostic factors by 12 months was done first using univariable analysis to identify significant factors in participants with no missing data. Then receiver operating characteristic (ROC) curves were used to establish the optimal cutoffs for significant continuous variables. Finally, a modified Poisson regression approach was performed to identify the best prediction model and was adjusted for confounders, using data from all participants, with missing values imputed. This study is registered with ClinicalTrials.gov, NCT02012764. FINDINGS: Between June 30, 2008, and Feb 24, 2020, 451 participants consented to participate in the CCP study and 122 (27%) individuals had subclinical synovitis at baseline, of whom 90 (74%) had data available at 12 months. Mean age was 54·1 years (SD 12·5), and 63 (70%) of 90 participants were women and 27 (30%) were men. Subclinical synovitis resolved in 43 (48%) of 90 participants, whereas subclinical synovitis persisted in 47 (52%) participants, 27 (57%) of whom developed clinical synovitis within 12 months. In the multivariable analysis, low anti-CCP titre (relative risk [RR] 1·52, 95% CI 1·04-2·22), negative rheumatoid factor (1·54, 0·92-2·58), subclinical synovitis in only one joint (1·62, 1·04-2·50), and an erythrocyte sedimentation rate of 15 mm/h or lower (1·82, 1·15-2·87) were predictors of subclinical synovitis resolution within 12 months (ie, good prognostic factors). ROC curve showed an area under the curve of 0·84 (95% CI 0·76-0·92; p<0·0001). Resolution occurred in seven (100%) of seven participants with all four factors present, and in only one (7%) of 14 participants with none of the factors present. INTERPRETATION: In individuals who were anti-CCP-positive, subclinical synovitis disappeared in approximately half of the participants by 12 months and was associated with the presence of good prognostic factors. Subclinical synovitis should be interpreted in the context of these additional factors. FUNDING: National Institute for Health Research Leeds Biomedical Research Centre.
引用
- Garcia-Montoya L, Kang J, Duquenne L, et al. Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study. Lancet Rheumatol. 2024. PMID: 38267105. doi:10.1016/S2665-9913(23)00305-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。